ADVM
Price
$4.82
Change
-$0.48 (-9.06%)
Updated
Oct 7, 12:59 PM (EDT)
Capitalization
111.22M
RGNX
Price
$10.46
Change
-$0.23 (-2.15%)
Updated
Oct 7, 02:19 PM (EDT)
Capitalization
540M
29 days until earnings call
Interact to see
Advertisement

ADVM vs RGNX

Header iconADVM vs RGNX Comparison
Open Charts ADVM vs RGNXBanner chart's image
Adverum Biotechnologies
Price$4.82
Change-$0.48 (-9.06%)
Volume$319
Capitalization111.22M
REGENXBIO
Price$10.46
Change-$0.23 (-2.15%)
Volume$100
Capitalization540M
ADVM vs RGNX Comparison Chart in %
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. RGNX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a StrongBuy and RGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (ADVM: $5.30 vs. RGNX: $10.69)
Brand notoriety: ADVM and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 64% vs. RGNX: 118%
Market capitalization -- ADVM: $111.22M vs. RGNX: $540M
ADVM [@Biotechnology] is valued at $111.22M. RGNX’s [@Biotechnology] market capitalization is $540M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADVM and RGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 4 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • ADVM’s TA Score: 4 bullish, 4 bearish.
  • RGNX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than ADVM.

Price Growth

ADVM (@Biotechnology) experienced а +15.22% price change this week, while RGNX (@Biotechnology) price change was +8.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.77%. For the same industry, the average monthly price growth was +17.22%, and the average quarterly price growth was +90.56%.

Reported Earning Dates

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+8.77% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($540M) has a higher market cap than ADVM($111M). RGNX YTD gains are higher at: 38.292 vs. ADVM (13.490). RGNX has higher annual earnings (EBITDA): -129.93M vs. ADVM (-172.21M). RGNX has more cash in the bank: 323M vs. ADVM (44.4M). RGNX has less debt than ADVM: RGNX (77.7M) vs ADVM (92.2M). RGNX has higher revenues than ADVM: RGNX (156M) vs ADVM (1M).
ADVMRGNXADVM / RGNX
Capitalization111M540M21%
EBITDA-172.21M-129.93M133%
Gain YTD13.49038.29235%
P/E RatioN/AN/A-
Revenue1M156M1%
Total Cash44.4M323M14%
Total Debt92.2M77.7M119%
FUNDAMENTALS RATINGS
ADVM vs RGNX: Fundamental Ratings
ADVM
RGNX
OUTLOOK RATING
1..100
312
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3643
P/E GROWTH RATING
1..100
10020
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADVM's Valuation (37) in the Biotechnology industry is somewhat better than the same rating for RGNX (71). This means that ADVM’s stock grew somewhat faster than RGNX’s over the last 12 months.

ADVM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RGNX (100). This means that ADVM’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's SMR Rating (98) in the Biotechnology industry is in the same range as ADVM (100). This means that RGNX’s stock grew similarly to ADVM’s over the last 12 months.

ADVM's Price Growth Rating (36) in the Biotechnology industry is in the same range as RGNX (43). This means that ADVM’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's P/E Growth Rating (20) in the Biotechnology industry is significantly better than the same rating for ADVM (100). This means that RGNX’s stock grew significantly faster than ADVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADVMRGNX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 23 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQFN15.05N/A
N/A
Equitable Financial Corp.
CNDCF9.61N/A
N/A
Canadian Banc Corp
MLXSF77.66N/A
N/A
Melexis NV
KGSPF85.45-0.45
-0.52%
Kingspan Group plc.
PTCO0.06-0.01
-13.24%
PetroGas Company

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with RGNX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
-1.67%
RGNX - ADVM
44%
Loosely correlated
+2.49%
CRNX - ADVM
43%
Loosely correlated
+2.01%
TENX - ADVM
43%
Loosely correlated
+2.13%
XNCR - ADVM
43%
Loosely correlated
+0.17%
XENE - ADVM
42%
Loosely correlated
-0.15%
More